August J Moretti
CIK 1344412 · Chief Financial Officer · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$97.5K
Companies
4
Total Filings
58
Lifetime Open-Market Net
-$1.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CBUS | Director | — | $1.23 | — | $0 | 3 | 2026-06-04 |
| FDMT | Chief Financial Officer | 11,045 | $8.83 | $97.5K | $0 | 7 | 2023-05-16 |
| Assertio Therapeutics, Inc (DEPO) Delisted | Chief Financial Officer & SVP | 74,447 | — | — | -$681.1K | 21 | 2018-04-03 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | SVP, CFO, GC & Sec | 99,419 | — | — | -$382.7K | 27 | 2011-08-01 |
Recent Filings · Page 6 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-01-03 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Mixed | — | -$32.6K | EDGAR |
| 2007-11-07 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | — | — | $0 | EDGAR |
| 2007-10-03 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Mixed | — | -$36.0K | EDGAR |
| 2007-08-01 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Mixed | −375 | -$36.4K | EDGAR |
| 2007-07-26 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-02 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | — | — | $0 | EDGAR |
| 2007-04-03 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Mixed | — | -$109.9K | EDGAR |
| 2007-01-08 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 51–58 of 58
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.